Skip to content
Clinical Trials – home

Betamethasone Dipropionate: A Comprehensive Guide for Patients

3 / 4
trials open to patients / all trials
4+
Countries

In short

Betamethasone dipropionate is a potent corticosteroid medication that has been the subject of several clinical trials investigating its effectiveness in treating various skin conditions. This article summarizes key findings from recent studies examining the use of betamethasone dipropionate, particularly in the treatment of psoriasis, lichen planus, and other inflammatory skin disorders. We'll explore its efficacy, application methods, and comparisons with other treatments to provide a comprehensive overview of its role in dermatological care.

At a glance

Primary Conditions Studied
Plaque psoriasis, scalp psoriasis, oral lichen planus
Formulations
Spray, foam, cream, gel, ointment
Typical Concentration
0.05%
Application Frequency
Once or twice daily
Treatment Duration
Varies by study, ranging from 5 days to 28 days
Outcome Measures
IGA, PASI, DLQI, BSA involvement, VAS pain score
Comparators
Clobetasol propionate, triamcinolone acetonide, placebo
Combination Therapies
Calcipotriol, clotrimazole
Safety Considerations
Skin atrophy, infection risk with long-term use
Patient Populations
Adults with mild to moderate psoriasis or lichen planus

What is Betamethasone Dipropionate?

Betamethasone Dipropionate is a topical corticosteroid medication used to treat various skin conditions and inflammatory disorders. It belongs to a class of drugs known as corticosteroids, which work by reducing inflammation and suppressing the immune system's response in affected areas. This medication is available in different formulations, including creams, ointments, gels, and foams, allowing for versatile application depending on the condition being treated.

Conditions Treated

Betamethasone Dipropionate is used to treat several conditions, including:

  • Plaque Psoriasis: A chronic autoimmune condition causing red, scaly patches on the skin
  • Scalp Psoriasis: A specific form of psoriasis affecting the scalp
  • Oral Lichen Planus (OLP): An inflammatory condition affecting the mucous membranes inside the mouth
  • Oral Submucous Fibrosis (OSF): A chronic, progressive condition affecting the oral cavity

These conditions are characterized by inflammation, discomfort, and in some cases, potential for malignancy. Betamethasone Dipropionate helps manage symptoms and slow disease progression.

Formulations and Applications

Betamethasone Dipropionate is available in various formulations to suit different treatment needs:

  • Topical Foam: Used for treating plaque psoriasis on the body
  • Topical Cream: Applied to affected skin areas for conditions like psoriasis and lichen planus
  • Topical Suspension: Specifically formulated for treating scalp psoriasis
  • Gel: Another form used for various skin conditions

The medication is typically applied once or twice daily, depending on the condition and formulation. It's important to follow your healthcare provider's instructions carefully for optimal results.

Effectiveness

Clinical studies have shown Betamethasone Dipropionate to be effective in treating various skin conditions:

  • In plaque psoriasis, it has demonstrated significant improvement in symptoms such as redness, scaling, and thickness of psoriatic plaques
  • For scalp psoriasis, the topical suspension has shown therapeutic equivalence to other established treatments
  • In oral lichen planus, Betamethasone Dipropionate has been effective in reducing pain, burning sensation, and improving overall quality of life

The effectiveness of the medication is often measured using scales such as the Investigator's Global Assessment (IGA), Psoriasis Area and Severity Index (PASI), and Dermatology Life Quality Index (DLQI).

Side Effects and Precautions

While Betamethasone Dipropionate is generally well-tolerated, it may cause some side effects, including:

  • Skin thinning or atrophy
  • Burning or itching at the application site
  • Increased risk of skin infections
  • Changes in skin pigmentation

Long-term use of topical corticosteroids like Betamethasone Dipropionate may lead to more serious side effects, such as adrenal suppression. It's important to use the medication as directed and inform your healthcare provider of any concerns.

Precautions should be taken when using this medication, especially on large areas of skin or for extended periods. Pregnant women and those with certain medical conditions should consult their healthcare provider before using Betamethasone Dipropionate.

Ongoing Research

Researchers continue to study Betamethasone Dipropionate to improve its effectiveness and explore new applications:

  • Combination therapies, such as Betamethasone Dipropionate with calcipotriol, are being investigated for enhanced efficacy in treating psoriasis
  • Studies are exploring the use of smartphone apps and electronic monitors to improve patient adherence to topical treatments, including Betamethasone Dipropionate
  • Comparative studies are being conducted to evaluate Betamethasone Dipropionate against other treatments for conditions like oral submucous fibrosis

These ongoing research efforts aim to enhance treatment outcomes and patient experiences with Betamethasone Dipropionate and related therapies.

Questions people often ask

Conditions where Betamethasone Dipropionate is being studied

Each condition opens its own overview and trial list

Trials with Betamethasone Dipropionate

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).